MAXIMUS Stock Price, News & Analysis (NYSE:MMS)

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS announced a quarterly dividend on Thursday, October 10th. Stockholders of record on Friday, November 15th will be paid a dividend of $0.28 per share on Friday, November 29th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date is Thursday, November 14th. This is an increase from MAXIMUS's previous quarterly dividend of $0.25. View MAXIMUS's Dividend History.

MAXIMUS declared that its board has initiated a share repurchase plan on Monday, June 25th 2018, which allows the company to buyback $200,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 4.9% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's board believes its shares are undervalued.

MAXIMUS, Inc. (NYSE:MMS) announced its quarterly earnings data on Thursday, August, 8th. The health services provider reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.93 by $0.04. The health services provider had revenue of $730.70 million for the quarter, compared to analyst estimates of $754.81 million. MAXIMUS had a net margin of 8.44% and a return on equity of 20.72%. The firm's quarterly revenue was up 22.2% on a year-over-year basis. During the same period last year, the business posted $0.91 EPS. View MAXIMUS's Earnings History.

MAXIMUS is scheduled to release their next quarterly earnings announcement on Tuesday, November 19th 2019. View Earnings Estimates for MAXIMUS.

MAXIMUS updated its FY19 earnings guidance on Thursday, August, 8th. The company provided earnings per share guidance of $3.70-3.75 for the period, compared to the Thomson Reuters consensus estimate of $3.70. The company issued revenue guidance of $2.92 billion, compared to the consensus revenue estimate of prior $3.65-3.75.

2 brokers have issued 1 year target prices for MAXIMUS's stock. Their forecasts range from $77.00 to $83.00. On average, they expect MAXIMUS's share price to reach $80.00 in the next year. This suggests a possible upside of 2.6% from the stock's current price. View Analyst Price Targets for MAXIMUS.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

News stories about MMS stock have been trending very negative this week, InfoTrie reports. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. MAXIMUS earned a coverage optimism score of -3.9 on InfoTrie's scale. They also assigned media headlines about the health services provider a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an effect on the company's share price in the immediate future. View News Stories for MAXIMUS.

MAXIMUS saw a decline in short interest during the month of September. As of September 30th, there was short interest totalling 1,330,000 shares, a decline of 17.4% from the August 30th total of 1,610,000 shares. Based on an average trading volume of 310,500 shares, the days-to-cover ratio is presently 4.3 days. Currently, 2.1% of the shares of the company are sold short. View MAXIMUS's Current Options Chain.

Some companies that are related to MAXIMUS include Visa (V), Mastercard (MA), Fidelity National Information Servcs (FIS), Automatic Data Processing (ADP), Worldpay (WP), Fiserv (FISV), Paychex (PAYX), FleetCor Technologies (FLT), Global Payments (GPN), Total System Services (TSS), Broadridge Financial Solutions (BR), Jack Henry & Associates (JKHY), The Western Union (WU), WEX (WEX) and Euronet Worldwide (EEFT).

Based on aggregate information from My MarketBeat watchlists, some companies that other MAXIMUS investors own include AGNC Investment (AGNC), Tesla (TSLA), Bank of America (BAC), Southwest Airlines (LUV), Adamis Pharmaceuticals (ADMP), ConforMIS (CFMS), JetBlue Airways (JBLU), NVIDIA (NVDA), QUALCOMM (QCOM) and Qorvo (QRVO).

MAXIMUS's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (0.75%), Robecosam AG (0.25%), Stephens Investment Management Group LLC (0.21%), Cambiar Investors LLC (0.10%), Rowland & Co. Investment Counsel ADV (0.04%) and Pacer Advisors Inc. (0.04%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Stephens Investment Management Group LLC, Riverbridge Partners LLC, Cambiar Investors LLC, Pacer Advisors Inc., Meeder Asset Management Inc., Robecosam AG and Crossmark Global Holdings Inc.. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

MMS stock was acquired by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC, Strs Ohio, State of Alaska Department of Revenue, Assenagon Asset Management S.A., Tuttle Tactical Management, Camelot Portfolios LLC, Envestnet Asset Management Inc. and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $78.00.

MAXIMUS has a market capitalization of $4.98 billion and generates $2.39 billion in revenue each year. The health services provider earns $220.75 million in net income (profit) each year or $3.40 on an earnings per share basis. MAXIMUS employs 18,600 workers across the globe.View Additional Information About MAXIMUS.

The official website for MAXIMUS is http://www.maximus.com/.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]